September 14-15, 2026
Renaissance London Heathrow Hotel, London, UK

3rd European Cancer and Oncology Congress

Theme : Empowering Global Oncology Through Innovation

About Cancer Congress 2026

The 3rd European Cancer and Oncology Congress, scheduled for September 14–15, 2026 in London, U.K, will be a premier forum for advancing cancer science and clinical care. Designed to foster collaboration and innovation, the event will convene oncologists, scientists, healthcare professionals, nurses, and researchers from across Europe and beyond to exchange knowledge, discuss new findings, and spotlight transformative developments in oncology.

Attendees can look forward to a rich and engaging program featuring high-impact keynote sessions from world-renowned experts, thought-provoking symposia, interactive workshops, and research poster showcases. The congress will delve into critical areas including precision oncology, immunotherapy, emerging treatment strategies, survivorship, palliative and supportive care, and the integration of digital tools and AI into oncology practice. Set against the stunning backdrop of London, this event offers an inspiring environment to connect, learn, and drive progress in cancer care.

Cancer Congress 2025

Intro Thumbnail

Sessions

Artificial Intelligence (AI) in Cancer
Cancer Drug Market & Clinical Trials in Oncology like this more and new and latest
3D Bioprinting & Organoids in Cancer Modeling
Non-metastatic and Metastatic NSCLC
Oncology Pharmacy and Drug Safety
Liquid Biopsies
Pediatric Oncology
Radiation Oncology & Surgical Oncology
Organ-specific Cancers
Cancer Nanotechnology
Blood Cancer
Oncology Nursing
Cancer & Oncology
Robotic and Integrative Oncology
Cancer Biology
Cancer Survivorship
Cancer Epidemiology
Sarcoma
Haematological Malignancies
Cancer Biomarkers
Gynecologic Oncology
Cancer Immunotherapy
Cancer Treatment & Therapy
Submit Your Abstract

Track Your Abstract

Important Dates

Abstract Submission Deadline: December 15, 2025

Early Bird Registration: December 16, 2025

Mid Term Registration: February 27, 2026

Final/Onsite Registration: September 14, 2026

International Organizing Committee

Rainer Lipp

GermanOncology

Germany

Amal A. Nasser

Phoenicia Medical Centre PMC

Lebanon

Pawan Kirtani

Aakash Healthcare Superspeciality Hospital

India

Vladimir Semiglazov

N.N. Petrov National Medical Research Center of Oncology

Russia

Why Attend Conference
  • Gain insights into the latest advancements in cancer research, treatment modalities, and breakthrough technologies from leading experts and researchers.
  • Connect with a diverse international audience of oncologists, clinicians, researchers, nurses, and industry professionals.
  • Participate in informative sessions and workshops covering a wide array of oncology topics.
  • Enhance your knowledge base and stay updated on current trends and best practices in cancer care.
  • Be inspired by keynote presentations, success stories, and the dedication of peers in the fight against cancer.
  • Contribute to discussions on shaping the future of cancer treatment and care.
  • Share your research findings, insights, and innovations that can potentially influence clinical practice and patient outcomes.
  • Experience the historic and vibrant city of Rome, known for its rich culture, art, and cuisine.
Explore

Gain insights into the breadth and depth of current research presented by researchers from around the globe.

Networking

Connect with peers, experts, and collaborators to expand your professional network.

Showcase

Share your research to foster collaborations, funding opportunities, and career advancements.
 

Supported Journals

Where to find us

Venue & Info

Event Venue

Renaissance London Heathrow Hotel, London, UK

Location Address
Bath Rd, Hounslow TW6 2AQ, United Kingdom
View All
Past Conference Report

Cancer Congress 2025

C2P Forum is pleased to announce the successful completion of the 2nd European Meeting on Cancer and Oncology, held on November 03-04, in Prague, Czech Republic.

The conference, themed “Exploring New Horizons in Oncology and Cancer Research,” concluded with great success.

We extend our sincere gratitude to the esteemed scientists, distinguished researchers, students and professionals from universities, research institutions, companies, and laboratories worldwide who contributed their latest insights and expertise in the field of Cancer and Oncology.

The conference featured a dynamic program, including keynote addresses, oral presentations, poster sessions, video presentation and E-Poster Presentations. The event was marked by significant engagement and outstanding contributions, and we are delighted to share some of the key highlights presented during the sessions:

•    Paola Dal Cin, Brigham and Women’s Hospital & Harvard Medical School, USA
•    Genia Burchall, Central Queensland University, Australia 
•    Avigdor Scherz, The Weizmann Institute of Science, Israel 
•    Giacomina Brunetti, University of Bari Aldo Moro, Italy 
•    Silvia Scaglione, National Research Council (CNR), Italy
•    Amal Assef Nasser, Phoenicia Medical Center (PMC), Lebanon 
•    Folinas Konstantinos, 251 Airforce General Hospital, Greece 
•    Martyna Pytlarz, Technical University of Denmark, Denmark 
•    Ch’ng You Qun, University Hospitals of Leicester NHS Trust, UK 
•    Laura Cerchia, Institute of Endotypes in Oncology, Metabolism and Immunology “G. Salvatore”- National Research Council (IEOMI-CNR), Italy 
•    Ella Fernandes, King's College London NHS Trust, UK 
•    Monica Fedele, Institute of Endotypes in Oncology, Metabolism and Immunology “G. Salvatore”- National Research Council (IEOMI-CNR), Italy 
•    Elena-Mihaela Vrabie, Fundeni Clinical Institute & Carol Davila University of Medicine and Pharmacy, Romania
•    Dan Cacsire Castillo-Tong, Medical University of Vienna, Austria
•    Daniel Tippner, Martin Luther University Halle-Wittenberg, Germany
•    Mónica G Mendoza-Rodríguez, Universidad Nacional Autónoma de México, México
•    Mike Alexander Celis Rodríguez, Universidad Industrial de Santander, Colombia
•    Morsal Sabihi, University Medical Center Hamburg-Eppendorf, Germany
•    Amira Mahmoud Ali Abdallah, Sheikh Shakhbout Medical City, UAE
•    Ferhat Bostanci, Istanbul Sabahattin Zaim University & Yıldız Technical University, Turkey
•    José Carlos Jaime-Pérez, Universidad Autónoma de Nuevo León, México
•    Andrada Nemesis Crișan & Roxana Elena Sicoe, Galaxy Medical Center, Romania
•    Rana Ajami, Ziv Medical Center, Israel
•    Elena Bukovetzky & Mona Nassar, Ziv Medical Center, Israel
•    Shivani Golem, University of Kansas Medical Center, USA
•    Swapnil Surpur, Wright Center for Graduate Medical Education, USA
•    Siqi Hua, Shanghai Jiao Tong University, China
•    Ema Ruszova, University Hospital Bulovka, Czech Republic

We would like to express our sincere appreciation to our Session Chairs Paola Dal Cin, Brigham and Women’s Hospital & Harvard Medical School, USA, Folinas Konstantinos, 251 Airforce General Hospital, Greece, & Avigdor Scherz, The Weizmann Institute of Science, Israel

Building on the success of the Cancer Congress 2025, we are pleased to announce our upcoming event, 3rd European Cancer and Oncology Congress on September 14-15, 2026 in London, UK

More info:  https://cancer.c2pforum.com/

Huge thanks to all the delegates! Your energy and involvement made this event a big success!

Mark your calendars and set your reminders.

Hope to meet you again in London, UK!!